Medex Acquires Vascular Access
Bio-Rad's Aspergillus EIA Test Kit Receives FDA 510(k) Clearance
Purdue to Market Spectracef Oral Antibiotic in the U.S.
NIH Awards HIV Grant to Antigen Express for Novel T-Helper Cell-Expanding Virus Vaccine
Parents Join Fight Against Meningococcal Meningitis in Newly Formed National Public Awareness Campaign Called "Moms On Meningitis"
Advanced Sterilization Products Releases the STERRAD CycleSure Self-Contained Biological Indicator
Response Biomedical Commercially Launches RAMP Pox Test for Environmental Detection of Smallpox
Coverall Cleaning Concepts Selected as Medical Cleaning Service Provider For Two South Florida Hospitals
'SARS-Ready' Software Debuts at Two U.S. Hospitals
Roche Diagnostics Receives FDA Authorization to Begin Clinical Trials for TaqScreen West Nile Virus Test
Rise in HIV/AIDS Cases Among Multicultural Communities in The South Spurs New Pfizer Foundation Grant Program
Collagen Matrix, Inc. Receives FDA Clearance for Matrix Collagen Particles Wound Dressing
Calgon Carbon Awarded a Second U.S. Patent for Protecting the Public From Cryptosporidium in Drinking Water
SARS Researchers in China Use SGI Technologies to Search for Genomic Clues and Anti-SARS Drugs
ActiPatch Therapy Designed to Heal Wounds, Reduce Pain and Swelling and Restore Patients to Normal Faster
FDA Clears Rapid Test for Aspergillus Infection
Alliance Medical Names Ron Clark Director of Research and Development
New Data Show Continued Efficacy of Rocephin Against Community-Acquired Pneumonia-Causing Bacteria
In Vitro Surveillance Study Shows Telithromycin Highly Active Against Resistant Strains of Streptococcus pneumoniae Compared With Commonly Used Antibiotics
Survey by American Dietetic Association Finds Many Travelers Risk Food Poisoning
Viragen Files Patent Application for Drug to Target SARS
Carts Re-Engineered for Easy Transport
Manufacturer Announces Sterilization Technology Breakthrough
U.S. Environmental Protection Agency Approves EnviroSystems' EcoTru for Use on Food Contact Surfaces
InterMune Announces Potent Antibiotic Activity of Oritavancin in In Vitro Studies Presented at ECCMID; Potency Against Resistant Bacterial Strains May Make Agent Important for Hospital Market
Hepatitis C Drug Market to Grow from $2.5 Billion in 2002 to More Than $9 Billion in 2012
Stryker Howmedica Osteonics Receives FDA Clearance for Simplex P With Tobramycin Antibiotic Bone Cement
Pressure Combined with Heat Reduces Prion Infectivity in Processed Meats
Sterion Incorporated Announces Sale of Sterilization Container Product Line to STERIS Corporation
IPM Hails Global HIV Prevention Working Group's Call for $1 Billion in Additional Public-Sector Spending on Microbicide R & D
